Hormone therapy for transgender patients
- PMID:28078219
- PMCID: PMC5182227
- DOI: 10.21037/tau.2016.09.04
Hormone therapy for transgender patients
Abstract
Many transgender men and women seek hormone therapy as part of the transition process. Exogenous testosterone is used in transgender men to induce virilization and suppress feminizing characteristics. In transgender women, exogenous estrogen is used to help feminize patients, and anti-androgens are used as adjuncts to help suppress masculinizing features. Guidelines exist to help providers choose appropriate candidates for hormone therapy, and act as a framework for choosing treatment regimens and managing surveillance in these patients. Cross-sex hormone therapy has been shown to have positive physical and psychological effects on the transitioning individual and is considered a mainstay treatment for many patients. Bone and cardiovascular health are important considerations in transgender patients on long-term hormones, and care should be taken to monitor certain metabolic indices while patients are on cross-sex hormone therapy.
Keywords: Hormone therapy; cross-sex hormones; gender dysphoria; transgender.
Conflict of interest statement
The author has no conflicts of interest to declare.
Similar articles
- Masculinizing Genital Gender Confirmation Surgery.Hadj-Moussa M, Agarwal S, Ohl DA, Kuzon WM Jr.Hadj-Moussa M, et al.Sex Med Rev. 2019 Jan;7(1):141-155. doi: 10.1016/j.sxmr.2018.06.004. Epub 2018 Aug 16.Sex Med Rev. 2019.PMID:30122339Review.
- Hormone Therapy for Transgender Adults.Radix A.Radix A.Urol Clin North Am. 2019 Nov;46(4):467-473. doi: 10.1016/j.ucl.2019.07.001. Epub 2019 Aug 19.Urol Clin North Am. 2019.PMID:31582021Review.
- Feminizing Genital Gender-Confirmation Surgery.Hadj-Moussa M, Ohl DA, Kuzon WM Jr.Hadj-Moussa M, et al.Sex Med Rev. 2018 Jul;6(3):457-468.e2. doi: 10.1016/j.sxmr.2017.11.005. Epub 2018 Feb 14.Sex Med Rev. 2018.PMID:29454634Review.
- A Review of Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults in South Korea.Oh JW, Yun Y, Lee ES.Oh JW, et al.J Menopausal Med. 2022 Dec;28(3):92-102. doi: 10.6118/jmm.22039.J Menopausal Med. 2022.PMID:36647272Free PMC article.Review.
- [Puberty Suppression for Adolescents with Gender Dysphoria A Japanese Perspective].Matsumoto Y.Matsumoto Y.Seishin Shinkeigaku Zasshi. 2017;119(1):42-51.Seishin Shinkeigaku Zasshi. 2017.PMID:30629867Japanese.
Cited by
- SeXX Matters in Multiple Sclerosis.Gilli F, DiSano KD, Pachner AR.Gilli F, et al.Front Neurol. 2020 Jul 3;11:616. doi: 10.3389/fneur.2020.00616. eCollection 2020.Front Neurol. 2020.PMID:32719651Free PMC article.Review.
- Chromosomal and gonadal factors regulate microglial sex effects in the aging brain.Ocañas SR, Ansere VA, Kellogg CM, Isola JVV, Chucair-Elliott AJ, Freeman WM.Ocañas SR, et al.Brain Res Bull. 2023 Apr;195:157-171. doi: 10.1016/j.brainresbull.2023.02.008. Epub 2023 Feb 15.Brain Res Bull. 2023.PMID:36804773Free PMC article.Review.
- Improving the annual monitoring rates of testosterone replacement therapy patients in primary care.Hassoun O, Starostka M, Shearer H, Millar A, Hassoun S, Isles C.Hassoun O, et al.BMJ Open Qual. 2022 Aug;11(3):e001784. doi: 10.1136/bmjoq-2021-001784.BMJ Open Qual. 2022.PMID:35914817Free PMC article.
- Transgender Care in the Primary Care Setting: A Review of Guidelines and Literature.Hashemi L, Weinreb J, Weimer AK, Weiss RL.Hashemi L, et al.Fed Pract. 2018 Jul;35(7):30-37.Fed Pract. 2018.PMID:30766372Free PMC article.
- Cardiovascular Disease in a Population-Based Sample of Transgender and Cisgender Adults.Poteat TC, Divsalar S, Streed CG Jr, Feldman JL, Bockting WO, Meyer IH.Poteat TC, et al.Am J Prev Med. 2021 Dec;61(6):804-811. doi: 10.1016/j.amepre.2021.05.019. Epub 2021 Aug 5.Am J Prev Med. 2021.PMID:34364725Free PMC article.
References
- Gates GJ. How Many People are Lesbian, Gay, Bisexual and Transgender? The Williams Institute, 2011.
Publication types
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources